| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: ARAY |
| Security Type |
Common Stock |
| Lead Underwriter |
JP Morgan UBS Investment Bank |
| Days In Registration |
86 |
| Date Filed |
13-Nov-2006 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2008) |
| Industry |
Manufacturing |
| Business Description |
Accuray Inc, located in Sunnyvale, California, manufactures stereotactic radiosurgical devices designed to treat tumors anywhere in the body. The company was founded in 1990. |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
52.21M |
| Contact |
- |
| Number of Employees |
14 |
|
| Original Filing Information |
| US |
| Shares Filed |
13.33M |
| Secondary Shares Filed | 6.0M |
| · As a Percent |
45.0 |
| Primary Shares Filed |
7.33M |
| · As a Percent |
55.0 |
| Overallotment Shares Filed |
2400.0K |
| File Amount |
$200.0M |
| File Price Range |
$16.00 - $14.00 |
| File Mid Price |
$15.00 |
Current Filing Information
(Amended 7-Feb-2007) |
|
US |
|
Shares Filed |
13.33M |
| Secondary Shares Filed |
6.0M |
| · As a Percent |
45.0 |
| Primary Shares Filed |
7.33M |
| · As a Percent |
55.0 |
| Overallotment Shares Filed |
- |
| File Amount |
$233.33M |
| · % Change from Original |
16.67 |
| File Price Range |
$18.00 - $17.00 |
| File Mid Price |
$17.50 |
|
